Vendor:JVS Technologies Pvt. Ltd.
From LIMSWiki
Jump to navigationJump to searchThe printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
| Type | Private limited company |
|---|---|
| Industry | Software development |
| Headquarters | A-401, Ganesh Plaza, Nr. Navrangpura Post Office, Navrangpura, Ahmedabad, Gujarat, India |
| Number of locations | 1 |
| Area served | India |
| Products |
Products list
|
| Website |
jvsgroup.com softclinicsoftware.com |
| https://www.linkedin.com/company/jvs-technologies-pvt.-ltd. |
JVS Technologies Pvt. Ltd.develops and distributes health informatics software solutions and develops custom software applications.
History
Technology and products
SoftClinic Platform
The SoftClinic Platform is described as cloud-based "scalable software with different modules like Laboratory, Pharmacy, HR, Inventory, and Accounting; thereby digitizing the basic management and record-keeping and making management tasks easier."[1] This includes SoftClinic ePharmacy, a pharmacy management system[2]; SoftClinic HIMS, a hospital information management system[3]; and SoftClinic LIS, a laboratory information system.[4]
Pricing
Pricing information not made public.
Demonstration videos and other media
Demonstration videos can be found on the company's YouTube channel.
Additional information
References
- ↑ "SoftClinic". JVS Technologies Pvt. Ltd. https://www.softclinicsoftware.com/. Retrieved 21 October 2020.
- ↑ "SoftClinic Pharmacy Management System". JVS Technologies Pvt. Ltd. https://www.softclinicsoftware.com/pharmacy-management-system-pms/. Retrieved 21 October 2020.
- ↑ "SoftClinic Hospital Information Management System". JVS Technologies Pvt. Ltd. https://www.softclinicsoftware.com/hospital-information-system-his/. Retrieved 21 October 2020.
- ↑ "SoftClinic Laboratory Information Software". JVS Technologies Pvt. Ltd. https://www.softclinicsoftware.com/laboratory-information-system-lis/. Retrieved 21 October 2020.
